Pages that link to "Q38500731"
Jump to navigation
Jump to search
The following pages link to Inflammatory signaling compromises cell responses to interferon alpha (Q38500731):
Displaying 27 items.
- Regulation of type I interferon responses (Q26853177) (← links)
- Ubiquitination-mediated regulation of interferon responses (Q26853323) (← links)
- Type 1 interferons contribute to the clearance of senescent cell (Q34044168) (← links)
- Modulation of TNF-induced macrophage polarization by synovial fibroblasts. (Q34053962) (← links)
- A robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFNβ drugs in the treatment of multiple sclerosis (Q35568496) (← links)
- Protein tyrosine phosphatase 1B is a key regulator of IFNAR1 endocytosis and a target for antiviral therapies (Q36437015) (← links)
- Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression (Q36784394) (← links)
- Eliminative signaling by Janus kinases: role in the downregulation of associated receptors (Q37377109) (← links)
- Ligation of CD180 inhibits IFN-α signaling in a Lyn-PI3K-BTK-dependent manner in B cells (Q37634933) (← links)
- Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury (Q37644388) (← links)
- The role of mitogen- and stress-activated protein kinase pathways in melanoma (Q37931402) (← links)
- Hope and fear for interferon: the receptor-centric outlook on the future of interferon therapy (Q38097519) (← links)
- Type I interferons: key players in normal skin and select cutaneous malignancies (Q38187119) (← links)
- Anti-metastatic functions of type 1 interferons: Foundation for the adjuvant therapy of cancer (Q38715458) (← links)
- Therapeutic Elimination of the Type 1 Interferon Receptor for Treating Psoriatic Skin Inflammation. (Q38760389) (← links)
- Role of interferon in melanoma: old hopes and new perspectives. (Q39168894) (← links)
- Type I Interferons Control Proliferation and Function of the Intestinal Epithelium (Q39253946) (← links)
- Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses (Q39264002) (← links)
- A Potent In Vivo Antitumor Efficacy of Novel Recombinant Type I Interferon (Q42293264) (← links)
- Downregulation of the IFNAR1 chain of type 1 interferon receptor contributes to the maintenance of the haematopoietic stem cells (Q50906975) (← links)
- Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment. (Q51138159) (← links)
- BRAF Inhibitors and IFNα: Plus, Minus, or Indeterminate? (Q55031113) (← links)
- Perspectives on interferon-alpha in the treatment of Polycythemia vera and related Myeloproliferative neoplasms: minimal residual disease and cure? (Q57159202) (← links)
- Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance (Q58729482) (← links)
- Viral dedication to vigorous destruction of interferon receptors (Q59356761) (← links)
- Expression of the IFNAR1 chain of type 1 interferon receptor in benign cells protects against progression of acute leukemia. (Q64938656) (← links)
- Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intratumoral stromagenesis (Q98513749) (← links)